Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

DARVON-N W/ ASA

ASPIRIN; PROPOXYPHENE NAPSYLATE

Standard Dose
325MG;100MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DARVON-N W/ ASA is listed in Drugs@FDA under application 016829 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ASPIRIN; PROPOXYPHENE NAPSYLATE Form and strength CAPSULE;ORAL - 325MG;100MG Sponsor AAIPHARMA LLC Submission history Latest submission status date: 1986-10-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview DARVON-N W/ ASA is listed in Drugs@FDA under application 016829 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ASPIRIN; PROPOXYPHENE NAPSYLATE Form and strength CAPSULE;ORAL - 325MG;100MG Sponsor AAIPHARMA LLC Submission history Latest submission status date: 1986-10-16 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
DARVON-N W/ ASA (ASPIRIN; PROPOXYPHENE NAPSYLATE) | Drug Monograph | MedicHelpline